/PRNewswire/ R2 Technologies Inc. ("R2"), the world leader in CryoAesthetic™ technology and the creator of Glacial® Rx, is celebrating the inauguration of.
DGAP-News: Heidelberg Pharma AG / Key word(s): Corporate ActionHeidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure 30.08.2022 / 17:41 CET/CESTThe issuer is solely responsible for the content of this announcement.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE.